NCT04134871

Brief Summary

People who have a severe mental illness can have poorer physical health and higher mortality rates than the general population. Their medications combined with low levels of physical activity and increased sedentary behaviour can general population and may help people with severe mental illness to be more active. A previous feasibility study has been conducted in the UK in a large city with positive findings. The current study will be conducted in rural settings in Northern Ireland and Republic of Ireland. The intervention will last 13 weeks. People with Severe Mental Illness will be randomly assigned into one of two groups. Both groups will get information on the benefits of physical activity. In addition, one group will be shown how to use a step counter to measure their steps, be invited to a weekly group walk, and meet their coach every 2 weeks contribute to this. Walking is a good way to increase physical activity in the to see how they are getting on and to support them. The research team are interested in finding out how willing clinicians are to recruit people into the study, how willing people are to take part, do people then stick with the programme, and if not the reasons for people dropping out. Qualitative findings will explore whether participants feel they benefited from and enjoyed the programme. Findings will be used to investigate the feasibility to conduct a larger trial like this in the future.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2019

Longer than P75 for not_applicable

Geographic Reach
2 countries

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 22, 2019

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

September 6, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 22, 2019

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

May 11, 2023

Status Verified

May 1, 2023

Enrollment Period

3.4 years

First QC Date

September 6, 2019

Last Update Submit

May 10, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Study recruitment rate

    The number of participants recruited to the study in relation to the number of individuals screened along with reasons for exclusion.

    Through study completion, approx. 18 months

  • Retention of study participants

    The number of participants that complete the study intervention versus the number of dropouts will be analysed along with reasons for drop out.

    Through study completion, approx. 18 months

  • Level of acceptability assessed by semi-structured interviews

    Semi-structured interviews will involve gaining information on participants' level of overall satisfaction with the intervention

    Data will be collected from participants at completion of the intervention, approx 3 months.

Secondary Outcomes (3)

  • Change in activity levels

    Data will be collected at baseline and at completion of intervention, approx 3 months.

  • Change in body weight (kilograms)

    Data will be collected at baseline and at completion of intervention, approx 3 months.

  • Change in waist circumference (cm)

    Data will be collected at baseline and at completion of intervention, approx 3 months.

Study Arms (2)

Intervention group

EXPERIMENTAL

Participants randomised to the intervention group will be invited to attend a group education session where they will be given a step counter and activity diary, they will be invited to weekly group walks and fortnightly coaching 1-1 sessions aimed at setting and reviewing goals to increase physical activity and reduce sedentary behaviour

Behavioral: Group walk and one to one coaching

Control group

NO INTERVENTION

Participants randomised to the control group will be given an information leaflet about being more active during a one-off 1-1 consultation.

Interventions

Participants will be invited to attend a group education session, weekly group walks and fortnightly coaching sessions

Intervention group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Inactive adults (Male or Female; aged ≥18 years)
  • Diagnosis of any SMI (schizophrenia, psychosis, bipolar disorder and major depression).

You may not qualify if:

  • Significant movement impairment
  • Identified as 'Active' using the GPPAQ screening tool
  • Unable to understand English or lack comprehension to understand the purpose of the study and given written informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Louth Meath Midlands HSE

Dundalk, Louth, Ireland

Location

Western HSCT

Omagh, Tyrone, United Kingdom

Location

Northern HSCT

Antrim, United Kingdom

Location

Related Publications (1)

  • McDonough SM, Howes SC, Dillon M, McAuley J, Brady J, Clarke M, Clarke M, Lait E, McArdle D, O'Neill T, Wilson I, Niven A, Williams J, Tully MA, Murphy MH, McDonough CM. A study protocol for a randomised controlled feasibility trial of an intervention to increase activity and reduce sedentary behaviour in people with severe mental illness: Walking fOR Health (WORtH) Study. Pilot Feasibility Stud. 2021 Nov 15;7(1):205. doi: 10.1186/s40814-021-00938-5.

MeSH Terms

Conditions

Mental DisordersSchizophreniaBipolar DisorderDepressive Disorder, MajorPsychotic Disorders

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersBipolar and Related DisordersMood DisordersDepressive Disorder

Study Officials

  • Suzanne M McDonough, PhD

    Ulster University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 6, 2019

First Posted

October 22, 2019

Study Start

August 22, 2019

Primary Completion

December 31, 2022

Study Completion

December 31, 2022

Last Updated

May 11, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations